Compare NORD & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NORD | BMHL |
|---|---|---|
| Founded | 1993 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.5M | 86.8M |
| IPO Year | 2005 | 2024 |
| Metric | NORD | BMHL |
|---|---|---|
| Price | $3.69 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 4.4K |
| Earning Date | 07-25-2017 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,346.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $66.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | N/A | $3.00 |
| 52 Week High | N/A | $6.35 |
| Indicator | NORD | BMHL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 30.69 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $3.87 |
| Average True Range (ATR) | 0.00 | 0.22 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 30.00 |
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
Bluemount Holdings Ltd through its operating subsidiaries, is a Hong Kong-based consulting and advisory, financial services, and luxury timepiece trading provider. The Company provides consulting and advisory services on business development strategies, including seeking suitable transaction projects for business development or diversification and suitable business partners or investors for fund-raising projects. Its services are centered around three core offerings: Business Transformation, Strategy, and Transactions. The Company also sources, buys, and sells brand-new luxury branded timepieces. It operates through two reportable segments: security-related services and asset management, and trading of timepieces, with the trading of timepieces generating maximum revenue.